Garden Stage Limited announced an Extraordinary General Meeting scheduled for August 26, 2026, to seek shareholder approval for increasing its authorized share capital from US$50,000 to US$1,000,000. This increase expands the Class A ordinary shares from 2,453,750 to 49,953,750, while maintaining 9,250,000 Class B ordinary shares. The company also proposes adopting a third amended and restated memorandum and articles of association. As of the July 29, 2026 record date, 1,462,399 Class A and 9,250,000 Class B shares were outstanding. Garden Stage Limited operates in the horticulture industry, specializing in the cultivation and sale of ornamental plants.

Garden Stage Limited filed this 6-K to correct inadvertent errors on the cover pages of several prospectus supplements. The amendments restate sales figures under General Instruction I.B.5 of Form F-3, noting securities sales of $1,489,999.50 for the April 9, 2025 supplement, $2,480,000 for the June 18, 2025 supplement, and $6,140,000 for the July 25, 2025 supplement. Additionally, the filing corrects the public float calculation as of September 15, 2025, stating the aggregate market value of outstanding Ordinary Shares held by non-affiliates was approximately $112,089,026.85, based on 64,393,265 shares at a $1.73 closing price. Garden Stage Limited is a company that operates in the unspecified sector via its ordinary shares.